A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults (NCT06843824) | Clinical Trial Compass
CompletedNot Applicable
A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults
China126 participantsStarted 2025-03-10
Plain-language summary
This study is a 4-week group controlled trial to explore whether graphene far-infrared intervention can improve the cognitive status of older adults presenting with symptoms of Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), or Alzheimer's Disease (AD), and is dedicated to enhancing the cognitive status of older adults and improving their mental health. Participants were older adults who presented with cognitive problems. Participants were divided into SCD and MCI/AD groups based on their cognitive level, and each group was further divided into a graphene far-infrared intervention group and a placebo control group. We also measured the depression and anxiety levels of the older adults and incidentally observed whether the graphene far-infrared intervention could have a positive impact on their mental health outcomes, which was not the focus of our study.
Who can participate
Age range
45 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 55 years and above (age limit may be relaxed to not less than 45 years if there is a special desire to participate in the intervention)
* No barriers to daily communication
* Individuals participating voluntarily
Exclusion Criteria:
* Good cognitive functioning (SCD score of 0)
* Subjective desire to withdraw
* Individuals who reported discomfort opting out during the experimental procedure
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial used graphene far-infrared technology to look at cognitive status in people with conditions like mild cognitive impairment and Alzheimer's disease — since the trial is already completed, has the results data been published anywhere, and what did they find about whether far-infrared exposure had any measurable effect on cognitive decline?
2The trial also looked at depression and anxiety symptoms alongside cognitive outcomes — given that I have both cognitive concerns and mood symptoms, is there any reason to think an approach like this could be relevant to my specific situation, or are there better-established treatments I should try first?
3Since this study is listed as Phase NA, which often means it was exploratory or a feasibility study rather than a full clinical trial, what does that mean for how much we can trust the results when it comes to safety and real benefit?
4Far-infrared therapy is not a standard medical treatment for cognitive impairment — is my doctor aware of this type of intervention, and are there any known risks or interactions I should understand before considering anything similar outside of a clinical trial setting?
5Since this trial has already completed recruitment and I cannot enroll, are there any currently open studies or evidence-based treatments for mild cognitive impairment or early Alzheimer's disease that my care team would recommend I look into instead?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
SCD
Timeframe: Pre-intervention, 2 weeks after the start of the intervention, 4 weeks after the start of the intervention (at which point the intervention ended), 2 weeks after the end of the intervention, and 4 weeks after the end of the intervention (a total of 5 mea
2
MCI/AD
Timeframe: Pre-intervention, 2 weeks after the start of the intervention, 4 weeks after the start of the intervention (at which point the intervention ended), 2 weeks after the end of the intervention, and 4 weeks after the end of the intervention (a total of 5 mea
Trial details
NCT IDNCT06843824
SponsorInstitute of Psychology, Chinese Academy of Sciences